EUVIMEDEUVIMED entdecken
Crossref

PEMT ‐mediated phospholipid imbalance promotes age‐associated metabolic dysfunction‐associated steatotic liver disease progression

Xilong Gao, Jiahui Gong, Yichao Hou, Li Lin, Yanling Hao, Zhengyuan Zhai, Ming Zhang, Hao Zhang, Juan Chen, Fa-Zheng Ren, Bing Fang iD, Liang Zhao iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Xilong Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Health, Key Laboratory of Functional Dairy, China Agricultural University, Beijing, China. Hauptthemen laut MEDLINE: Phosphatidylethanolamine N-Methyltransferase, Phospholipids, Non-alcoholic Fatty Liver Disease, Aging. Die Arbeit nennt 41 Literaturangaben. Gefördert von: the 2115 Talent Development Program of China Agricultural University, the 111 Project from the Ministry of Education of China, the National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction‐associated steatotic liver disease [MASLD; previously known as nonalcoholic fatty liver disease (NAFLD)] is a prevalent chronic liver disorder strongly associated with aging, yet the mechanisms underlying age‐related hepatic lipid dysregulation remain incompletely defined. This study investigates how aging alters hepatic phospholipid metabolism and the contribution of phosphatidylethanolamine N‐methyltransferase (PEMT) to MASLD progression. Here, lipid accumulation was characterized in the livers of 2‐, 6‐, 12‐, 18‐, and 24‐month‐old mice, revealing age‐dependent increases in hepatic triacylglycerol (TG), total cholesterol (TC), and lipid droplet formation. Lipidomic analysis revealed a marked imbalance in phospholipid composition, characterized by increased phosphatidylcholine (PC) and decreased phosphatidylethanolamine (PE), resulting in a 2.5‐fold increase in the PC/PE ratio in 24‐month‐old mice compared with 6‐month‐old controls. Mechanistically, PEMT, a key enzyme regulating PC and PE metabolism, exhibited significantly increased expression (~2.4‐fold at the protein level) in aged livers, suggesting a pivotal role in driving the observed phospholipid imbalance in vitro . PEMT inhibition significantly attenuated lipid droplet accumulation by ~30% and reduced intracellular TG levels by ~20% in D‐galactose‐induced senescent AML12 hepatocytes under lipid stress, compared with nonsilenced senescent controls. These findings suggest that aging‐driven PEMT overexpression promotes phospholipid remodeling and hepatic lipid accumulation. By leveraging a natural aging mouse model, our study provides the first evidence linking PEMT activity to age‐associated phospholipid dyshomeostasis, revealing a previously unknown mechanistic axis distinct from diet‐induced MASLD and offering new therapeutic insights.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylethanolamine N-MethyltransferasePhospholipidsNon-alcoholic Fatty Liver DiseaseAgingAnimalsMiceDisease ProgressionLiverPhosphatidylcholinesPhosphatidylethanolaminesMaleLipid MetabolismMice, Inbred C57BLTriglycerides

Stichwörter der Autor:innen

PC/PE ratioPEMTaging liverhepatic lipid accumulationphospholipid metabolism

Substanzen

Phosphatidylethanolamine N-MethyltransferasePhospholipidsPEMT protein, mousePhosphatidylcholinesPhosphatidylethanolaminesTriglyceridesphosphatidylethanolamine

Autor:innen und Institutionen

  • Department of Nutrition and Health, Key Laboratory of Functional Dairy, China Agricultural University, Beijing, China.
  • College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
  • School of Food and Health, Beijing Technology and Business University, China.
  • Research Center for Probiotics, China Agricultural University, Beijing, China.

ORCID-Profile: Bing Fang, Liang Zhao

Förderung

  • the 2115 Talent Development Program of China Agricultural University
  • the 111 Project from the Ministry of Education of China
  • the National Key Research and Development Program of China

Zitieren

APA

Gao, X., Gong, J., Hou, Y., Lin, L., Hao, Y., Zhai, Z., Zhang, M., Zhang, H., Chen, J., Ren, F. Z., Fang, B., & Zhao, L. (2025). PEMT ‐mediated phospholipid imbalance promotes age‐associated metabolic dysfunction‐associated steatotic liver disease progression. The FEBS Journal. https://doi.org/10.1111/febs.70349

Vancouver

Gao X, Gong J, Hou Y, Lin L, Hao Y, Zhai Z, et al. PEMT ‐mediated phospholipid imbalance promotes age‐associated metabolic dysfunction‐associated steatotic liver disease progression. The FEBS Journal. 2025. doi:10.1111/febs.70349

BibTeX
@article{Gao2025,
  author = {Gao, Xilong and Gong, Jiahui and Hou, Yichao and Lin, Li and Hao, Yanling and Zhai, Zhengyuan and Zhang, Ming and Zhang, Hao and Chen, Juan and Ren, Fa-Zheng and Fang, Bing and Zhao, Liang},
  title = {PEMT ‐mediated phospholipid imbalance promotes age‐associated metabolic dysfunction‐associated steatotic liver disease progression},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70349}
}
Kostenlos starten →